KICVentures is seeking investors to ready AxioMed and NanoFuse Biologics for possible acquisition in the next three to five years.
What you should know:
1. KICVentures will be at the American Academy of Orthopedic Surgeons annual meeting in Las Vegas, March 12-16.
2. The investments will be used to prepare AxioMed and NanoFuse for a possible acquisition.
3. KICVentures is seeking a minimum investment of $25,000.
4. KICVentures Founder Kingsley R. Chin, MD, said, "Consolidation and market expansion will continue for the next five years as larger device players respond to growth pressures and to new innovations in the areas of motion preservation and biologics."